Joint effusion at 6 months is a significant predictor of joint effusion 1 year after anterior cruciate ligament reconstruction
Purpose This study aimed to assess the risk factors for prolonged joint effusion in patients undergoing double-bundle anterior cruciate ligament reconstruction (ACLR). Methods In total, 160 patients who underwent primary ACLR using autograft hamstring between 2015 and 2018 were retrospectively revie...
Gespeichert in:
Veröffentlicht in: | Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA sports traumatology, arthroscopy : official journal of the ESSKA, 2021-11, Vol.29 (11), p.3839-3845 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Purpose
This study aimed to assess the risk factors for prolonged joint effusion in patients undergoing double-bundle anterior cruciate ligament reconstruction (ACLR).
Methods
In total, 160 patients who underwent primary ACLR using autograft hamstring between 2015 and 2018 were retrospectively reviewed. Joint effusion was defined as any grade ≥ 2 (range, 0–3) according to the MRI Osteoarthritis Knee Score (MOAKS). Univariate and multivariate logistic regression analyses were performed.
Results
The median age of the patients was 25 years (range 14–68 years) at the time of the surgery; there were 89 women and 71 men. At 1 year, 46 (28.8%) patients experienced knee joint effusion, as defined by the MOAKS. Univariate analysis revealed that age, preoperative Kellgren–Lawrence (K–L) grade, and joint effusion at 6 months were significantly associated with joint effusion at 1 year. In the multivariate analysis, joint effusion at 6 months was significantly associated with joint effusion at 1 year (odds ratio, 68.0; 95% confidence interval, 22.1–209.4). No significant difference in the Lysholm scores was observed between patients with and without joint effusion at 1 year (n.s.).
Conclusions
Joint effusion at 6 months was significantly associated with joint effusion 1 year after ACLR.
Level of evidence
III. |
---|---|
ISSN: | 0942-2056 1433-7347 |
DOI: | 10.1007/s00167-021-06433-x |